Life Sciences Degron Therapeutics Raises $22 Million Series A Financing to Accelerate Growth and Expand… AIT News Desk Jun 10, 2022 Degron Therapeutics ("Degron"), a biotechnology company developing a new class of small-molecule medicines that target previously undruggable targets,…
Life Sciences Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of… AIT News Desk Jun 2, 2022 Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, announced that…
Machine Learning InveniAI and Kyowa Kirin Announce Achievement of Milestone in Research Collaboration AIT News Desk May 31, 2022 - Collaboration poised to exploit synergistic drug discovery and development engine to enable innovation at scale by InveniAI and validation of…
Life Sciences Endeavor BioMedicines Partners with xCures to Identify Patients with PTCH1 Mutations for Phase 2… AIT News Desk May 31, 2022 xCures to use tumor sequencing information and its platform to pair patients with available treatment options Endeavor BioMedicines, a…
Life Sciences John Hopkin’s University Publishes Efficacy of QuadraMune Ingredient Sulforaphane at Inhibiting… AIT News Desk May 28, 2022 Commercially Available Nutraceutical Developed by Phase III Stem Cell Biotechnology Company Continues to Receive Independent Validation of…
Life Sciences Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory… AIT News Desk May 27, 2022 Adicet Bio, Inc., a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor…
Life Sciences Nuritas Announces North American Headquarters, CEO to Relocate to US AIT News Desk May 24, 2022 Biotech company sharing first details for its commercial and scientific base in Connecticut during the Yale Innovation Summit Nuritas, a…
Life Sciences Ocugen Announces FDA Removes Clinical Hold on Phase 2/3 Clinical Trial for COVAXIN AIT News Desk May 23, 2022 Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines,…
Machine Learning PostEra Spearheads AI-driven Drug Discovery Collaboration to Develop Antiviral Therapeutics with… AIT News Desk May 20, 2022 PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, announced a multi-year collaboration with the…
Life Sciences CytoTronics Launches with $9.25 Million in Seed Funding to Revolutionize Drug Discovery and… AIT News Desk Apr 30, 2022 Harvard University spinout advances a unique complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform that opens a new…